Effects of estrogen on cognition, mood, and cerebral blood flow in AD: A controlled study

Neurology

Volumn 54, Issue 11, 2000, Pages 2061-2066

  Wang, P N ^a   Liao, S Q ^a   Liu, R S ^a   Liu, C Y ^b   Chao, H T ^a   Lu, S R ^a   Yu, H Y ^a   Wang, S J ^a   Liu, H C ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

AD; Cerebral blood perfusion; Cognition; Dementia; Depression; Estrogen

Indexed keywords

CONJUGATED ESTROGEN;

ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ESTROGEN ACTIVITY; FEMALE; HUMAN; MOOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034643897     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.11.2061     Document Type: Article

References (37)

1. Felson DT, Zhang Y, Hannan MT, Kiel DP, Wilson PWF, Anderson JJ. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 1993;329: 1141-1146.
2. Stampfer MJ, Colditz GA, Willet WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991; 325:756-762.
3. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 1998;279:688-695.
4. McEwen BS, Woolley CS. Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain. Exp Gerontol 1994;29:431-436.
5. Luine VN. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 1985;89:484-490.
6. Applebaum-Bowden D, McLean P, Steinmetz A, et al. Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women. J Lipid Res 1989;30:1895-1906.
7. Jaffe AB Toran-Allerand CD, Greengard P, Gandy SE. Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. J Biol Chem 1994;269:13065-13068.
8. Sullivan TJ, Karas RH, Aronovitx M, et al. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest 1995;96:2482-2488.
9. Campbell S, Whitehead M. Estrogen therapy and the menopausal syndrome. Clin Obstet Gynecol 1977;4:31-47.
10. Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992;17:485-495.
11. Ditkoff EC, Crary WG, Cristo M, Lobo RA. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 1991;78:991-995.
12. Tang MX Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429-432.
13. Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 1997;48:1517-1521.
14. Fillit H, Weinreb H, Cholst I, et al. Observations in a preliminary open trial of estradiol therapy for senile dementia (Alzheimer's type). Psychoneuroendocrinology 1986;11:337-345.
15. Honjo H, Ogino Y, Naitoh K, et al. In vivo effects by estrone sulfate on the central nervous system - senile dementia (Alzheimer's disease). J Steroid Biochem 1989;34:521-525.
16. Honjo H, Ogino Y, Naitoh K, et al. An effect of conjugated estrogen to cognitive impairment in women with senile dementia-Alzheimer's type: a placebo-controlled double blind study. J Jpn Menopause Soc 1993;1:167-171.
17. Ohkura T, Isse K, Akazawa K, Hamamoto M, Yaoi Y, Hagino N Evaluation of estrogen treatment in female patients with dementia of the Alzheimer's type. Endocr J 1994;41:361-371.
18. Ohkura T, Isse K, Akazawa K, Hamamoto M, Yaoi Y, Hagino N Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: 7 case reports. Dementia 1995;6:99-107.
19. Henderson VW, Watt L, Buckwalter JG. Cognitive skills associated with estrogen replacement in women with Alzheimer's disease. Psychoneuroendocrinology 1996;21:421-430.
20. Mckahnn G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINADS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
21. Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
22. Hughe CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572.
23. Hachinski VC, Iliff LD, Zilhka E, et al. Cerebral blood flow in dementia. Arch Neurol 1975;32:632-637.
24. Teng EL Cross-cultural testing and the Cognitive Abilities Screening Instrument (CASI). In: Yeo G, Gallagher-Thompson D, eds. Ethnicity and the dementias. Washington, DC: Taylor & Francis, 1996:77-85.
25. Graves AB, Rajaram L, Bowen J, McCormick WC, McCurry SM, Larson EB. Cognitive decline and Japanese culture in a cohort of older Japanese Americans in King County, WA: the Kame Project. J Gerontol Soc Sci 1999:54B:S154-S161.
26. Liu HC Fuh JL, Wang SJ, et al. Prevalence and subtypes of dementia in a rural Chinese population. Alzheimer Dis Assoc Disord 1998;12:127-134.
27. Graves AB, Larson EB, Kukull WA, White LR, Teng EL. Screening for dementia in the community in cross-national studies: comparison between the Cognitive Abilities Screening Instrument and the Mini-Mental State Examination. In: Corain B, Iqbal K, Nicolini M, Winblad B, Wisniewski H, Zatta P, eds Alzheimer's disease: advances in clinical and basic research. Chichester, UK: Wiley & Sons, 1993:113-119.
28. Schneider LS, Olin JY, Doody RS, et al. Validity and reliability of the Alzheimer's disease cooperative study clinical global impression of change. Alzheimer Dis Assoc Disord 1997; 11(suppl. 2):S22-S32.
29. Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Georgotas A. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry 1987; 48(suppl 5):9-15.
30. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
31. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-55.
32. Honjo H, Kitawaki J, Itoh M, et al. Serum and urinary oestrone sulfate in pregnancy and delivery measured by a direct radioimmunoassay. Endocrinol (Copenh) 1986;112:423-430.
33. Gattaneo S, Forti G, Fiorelli G, et al. A rapid radioimmunoassay for determination of dehydroepiandrosterone sulfate in human plasma. Clin Endocrinol 1975;4:505-512.
34. Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988;13:345-357.
35. Resnick SM, Metter EJ, Zonderman AB. Estrogen replacement therapy and longitudinal decline in visual memory: a possible protective effect? Neurology 1997;49:1491-1497.
36. Robinson D, Friedman L, Marcus R, Tinklenberg J, Yesavage J. Estrogen replacement therapy and memory in older women. J Am Geriatr Soc 1994;42:919-922.
37. Schneider LS, Farlow MR, Henderson VW, Pogoda JM. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology 1996;46: 1580-1584.